The investigation regarding the analysis of cost-effectiveness and the rationalization of medical cost with or without preventive intervention

根据我们根据卫生账户体系(SHA)估算的结果，我们估算了日本的终身卫生支出。终身保健支出从1682万日元增加到1762万日元，国民终身保健支出占1924万日元。此外，预期寿命健康支出估计为1260万日元。通过估算，我们能够提高卫生总费用的国际可比性，并提供有助于评估卫生政策的统计数据。希望这方面的研究继续考虑以医疗费用多阶段分析为基础的医疗改革，然后通过医疗保健和预防的行为模型来评估和挑选适合疾病管理的疾病。预见性投资可以通过预防行为控制医疗费用，提高卫生服务质量。

We estimated the lifelong health expenditure of Japan based on the findings we have ever estimated in accordance with System of Health Accounts (SHA). The lifelong health expenditure reached form 16,820 thousand yen to 17,620 thousand yen, and the national lifelong healthcare expenditure accounted it for 19,240 thousand yen. Moreover, the life expectancy health expenditure was estimated 12,600 thousand yen. Through the estimation, we are able to improve the international comparability of total health expenditure, and to provide the statistics which were helpful to assess the healthcare policy. It is hoped that research about this be continued to consider the health care reform which bases the multiphase analysis over the health expenditure, and then we evaluated and picked up the appropriate diseases for disease management through behavior models on medical care and prevention. An anticipatory investment could curb medical expenses and improve the quality of health care through the preventive behavior.